NEW YORK, March 20, 2017 /PRNewswire/ --
Today's focus is on Agricultural Chemicals, which is a large and highly regulated sub-industry under the Chemicals industry. It includes a broad range of pesticides, herbicides, insecticides, and fungicides, as well as synthetic fertilizers, hormones and other chemical growth agents. Pre-market today, Stock-Callers.com takes note of the recent performances of Intrepid Potash Inc. (NYSE: IPI), Monsanto Co. (NYSE: MON), Syngenta AG (NYSE: SYT), and CVR Partners L.P. (NYSE: UAN). Sign up today and download for free the research reports for the stocks covered today at:
Denver, Colorado-based Intrepid Potash Inc.'s shares recorded a trading volume of 2.76 million shares last Friday, which was above their three months average volume of 1.80 million shares. The stock finished the trading session 5.00% higher at $1.47. The Company's shares are trading below their 200-day moving average by 5.48%. Furthermore, shares of Intrepid Potash, which engages in the extraction, production, and sale of potassium containing products in the US, have a Relative Strength Index (RSI) of 33.50.
On March 16th, 2017, Intrepid Potash announced that it has priced its previously announced underwritten public offering of 43,541,667 shares of its common stock. Intrepid has granted the underwriter a 30-day option to purchase up to 6,531,250 additional shares of common stock. Intrepid expects to receive total gross proceeds of approximately $52.3 million, or approximately $60.1 million if the underwriter exercises its option to purchase additional shares of common stock in full. The net proceeds from this offering are to be used to partially repay indebtedness outstanding under Intrepid`s senior notes and for general corporate purposes. The sale of the common stock is expected to settle on March 21st, 2017. IPI complete research report is just a click away at:
On Friday, St. Louis, Missouri headquartered Monsanto Co.'s stock ended the session 0.22% higher at $112.76. A total volume of 4.99 million shares was traded, which was above their three months average volume of 1.78 million shares. The Company's shares have gained 3.64% in the last one month, 8.65% over the previous three months, and 7.73% on an YTD basis. The stock is trading 2.35% above its 50-day moving average and 7.37% above its 200-day moving average. Moreover, shares of Monsanto, which together with its subsidiaries, provides agricultural products for farmers worldwide, have an RSI of 53.40.
On January 27th, 2017, Monsanto announced that its Board of Directors declared a quarterly dividend on its common stock of $0.54 per share. The dividend is payable on April 28th, 2017, to shareowners of record on April 07th, 2017.
On February 23rd, 2017, research firm RBC Capital Markets initiated a 'Sector Perform' rating on the Company's stock, with a target price of $118 per share. The complimentary report on MON can be downloaded at:
Basel, Switzerland headquartered Syngenta AG's stock ended the day 0.23% lower at $88.28. A total volume of 887,385 shares was traded, which was higher than their three months average volume of 608,770 shares. The Company's shares have gained 2.88% in the last month, 10.43% over the previous three months, and 11.68% on an YTD basis. The stock is trading 3.55% and 7.38% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Syngenta, which engages in the crop protection, seeds, and lawn and garden markets worldwide, have an RSI of 65.45.
On March 17th, 2017, Syngenta announced that the registration of its SDHI fungicide SOLATENOL™ has been further extended in Europe following approval by the German authorities. This most recent registration will allow Syngenta to introduce the products ELATUS™ Era and ELATUS™ Plus to the cereals market in Germany. Sign up for your complimentary report on SYT at:
Shares in Sugar Land, Texas-based CVR Partners L.P. recorded a trading volume of 743,060 shares, which was above their three months average volume of 511,510 shares. The stock ended Friday's session 2.81% lower at $4.50. The Company's shares are trading below their 50-day moving average by 23.06%. Furthermore, shares of CVR Partners, which produces, distributes, and markets nitrogen fertilizer products in North America, have an RSI 28.46.
On February 16th, 2017, CVR Partners announced Q4 2016 net loss of $14.5 million, or $0.13 per common unit, on net sales of $84.9 million compared to net income of $18.7 million, or 26 cents per common unit, on net sales of $66.0 million for Q4 2015. The Company's adjusted EBITDA was $18.3 million for Q4 2016 compared to adjusted EBITDA of $28.5 million for Q4 2015. Download the research report for free on UAN at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44-330-808-3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA